Volume therapy with hydroxyethyl starches: are we throwing the anesthesia baby out with the intensive care unit bathwater?

Anesth Analg. 2014 Sep;119(3):737-739. doi: 10.1213/ANE.0000000000000221.

Authors

Michael G Irwin¹, Tong J Gan

Affiliation

¹ From the Department of Anaesthesiology, The University of Hong Kong, Pokfulam, Hong Kong; and Department of Anesthesiology, Duke University, Durham, North Carolina.

PMID: 25137005
DOI: 10.1213/ANE.0000000000000221

No abstract available

MeSH terms

Blood Volume / physiology*
Critical Care / methods*
Drug Industry / ethics
Europe
Evidence-Based Medicine
Humans
Hydroxyethyl Starch Derivatives / adverse effects*
Hydroxyethyl Starch Derivatives / therapeutic use*
Hypovolemia / drug therapy*
Intensive Care Units
Kidney Diseases / chemically induced
Meta-Analysis as Topic
Plasma Substitutes / adverse effects*
Plasma Substitutes / therapeutic use*
Postoperative Complications / chemically induced
Postoperative Complications / mortality
Product Recalls and Withdrawals
United States
United States Food and Drug Administration

Substances

Hydroxyethyl Starch Derivatives
Plasma Substitutes